Nivolumab vs Sacubitril-Valsartan

## Nivolumab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Sacubitril-Valsartan**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Sacubitril-Valsartan**: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Sacubitril-Valsartan — 11.5 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Sacubitril-Valsartan — C24H29N2O5.

**Molecular Weight**: Nivolumab — N/A; Sacubitril-Valsartan — 414.5010 g/mol.

**Type**: Nivolumab — Antibody; Sacubitril-Valsartan — Small molecule.